Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (141-150 of 418) with videos related to

Pageof 42
Sort By:
International Journal of Cancer|August 13, 2025
Postnatal determinants of testicular germ cell tumor by histological subtypes: The EPSAM1 and EPSAM2 studiesMauro Cioffi, Giovenale Moirano, Elena Isaevska, et al.
Scientific Reports|November 20, 2018
Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysisFrancesco Passiglia, Sergio Rizzo, Massimo Di Maio, et al.
Oncology Reports|March 27, 2012
Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and meta-analysis of randomized controlled trialsDomenico Ciliberto, Ubaldo Prati, Laura Roveda, et al.
Cancer|March 11, 2023
Real-world retrospective study of KRAS mutations in advanced non-small cell lung cancer in the era of immunotherapyPaolo Bironzo, Massimiliano Cani, Francesca Jacobs, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 10, 2011
Maintenance therapy in NSCLC: why? To whom? Which agent?Silvia Novello, Michele Milella, Marcello Tiseo, et al.
Critical Reviews in Oncology/Hematology|August 12, 2018
Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysisVincenzo Di Nunno, Emmanuele De Luca, Consuelo Buttigliero, et al.
Plos One|July 13, 2016
What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research ActivitiesAnna Moretti, Michele Ghidini, Carmine De Angelis, et al.
Frontiers in Oncology|October 8, 2025
A network meta-analysis of the safety of systemic treatments in patients with metastatic hormone-sensitive prostate cancerMassimo Di Maio, Enrique Gonzalez-Billalabeitia, Laura Marandino, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 23, 2026
Stakeholder perspectives on potential open-label bias in patient-reported outcome results from cancer clinical trials: evidence from the IMPROvE projectFabio Efficace, Daniela Krepper, Francesco Sparano, et al.
La Radiologia Medica|September 8, 2016
Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapyMarco Tampellini, Dario Gned, Chiara Baratelli, et al.
Pageof 42

Showing results (141-150 of 418) with videos related to

Sort By:
Pageof 42
International Journal of Cancer|August 13, 2025
Postnatal determinants of testicular germ cell tumor by histological subtypes: The EPSAM1 and EPSAM2 studiesMauro Cioffi, Giovenale Moirano, Elena Isaevska, et al.
Scientific Reports|November 20, 2018
Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysisFrancesco Passiglia, Sergio Rizzo, Massimo Di Maio, et al.
Oncology Reports|March 27, 2012
Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and meta-analysis of randomized controlled trialsDomenico Ciliberto, Ubaldo Prati, Laura Roveda, et al.
Cancer|March 11, 2023
Real-world retrospective study of KRAS mutations in advanced non-small cell lung cancer in the era of immunotherapyPaolo Bironzo, Massimiliano Cani, Francesca Jacobs, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 10, 2011
Maintenance therapy in NSCLC: why? To whom? Which agent?Silvia Novello, Michele Milella, Marcello Tiseo, et al.
Critical Reviews in Oncology/Hematology|August 12, 2018
Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysisVincenzo Di Nunno, Emmanuele De Luca, Consuelo Buttigliero, et al.
Plos One|July 13, 2016
What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research ActivitiesAnna Moretti, Michele Ghidini, Carmine De Angelis, et al.
Frontiers in Oncology|October 8, 2025
A network meta-analysis of the safety of systemic treatments in patients with metastatic hormone-sensitive prostate cancerMassimo Di Maio, Enrique Gonzalez-Billalabeitia, Laura Marandino, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 23, 2026
Stakeholder perspectives on potential open-label bias in patient-reported outcome results from cancer clinical trials: evidence from the IMPROvE projectFabio Efficace, Daniela Krepper, Francesco Sparano, et al.
La Radiologia Medica|September 8, 2016
Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapyMarco Tampellini, Dario Gned, Chiara Baratelli, et al.
Pageof 42